Authors: Gobin, SJP Montagne, L Van Zutphen, M Van der Valk, P Van den Elsen, PJ De Groot, CJA

Citation: Sjp. Gobin et al., Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions, GLIA, 36(1), 2001, pp. 68-77

Authors: Peijnenburg, A Van den Berg, R Van Eggermond, MJCA Sanal, O Vossen, JMJJ Lennon, AM Alcaide-Loridan, C Van den Elsen, PJ

Citation: A. Peijnenburg et al., Defective MHC class II expression in an MHC class II deficiency patient iscaused by a novel deletion of a splice donor site in the MHC class II transactivator gene, IMMUNOGENET, 51(1), 2000, pp. 42-49

Authors: Ramirez-Montagut, T Andrews, DM Ihara, A Pervaiz, S Pandolfi, F Van den Elsen, PJ Waitkus, R Boyle, LA Hishii, M Kurnick, JT

Citation: T. Ramirez-montagut et al., Melanoma antigen recognition by tumour-infiltrating T lymphocytes (TIL): effect of differential expression of Melan-A/MART-1, CLIN EXP IM, 119(1), 2000, pp. 11-18

Authors: Peijnenburg, A Van Eggermond, MCJA Van den Berg, R Sanal, O Vossen, JMJJ Van den Elsen, PJ

Citation: A. Peijnenburg et al., Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene, IMMUNOGENET, 49(4), 1999, pp. 338-345

Authors: Gobin, SJP Keijsers, V Cheong, C van Zutphen, M Van den Elsen, PJ

Citation: Sjp. Gobin et al., Transcriptional regulation of HLA-G, TRANSPLAN P, 31(4), 1999, pp. 1857-1859

Authors: Peijnenburg, A Van Eggermond, MJCA Gobin, SJP Van den Berg, R Godthelp, BC Vossen, JMJJ Van den Elsen, PJ

Citation: A. Peijnenburg et al., Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5, J IMMUNOL, 163(2), 1999, pp. 794-801